Bradley Canino

Stock Analyst at Stifel

(1.64)
# 3,380
Out of 5,026 analysts
88
Total ratings
32.91%
Success rate
-1.5%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Bradley Canino

Syndax Pharmaceuticals
Sep 10, 2025
Reinstates: Buy
Price Target: $44
Current: $15.05
Upside: +192.36%
Janux Therapeutics
Sep 10, 2025
Reinstates: Buy
Price Target: $45
Current: $27.20
Upside: +65.44%
Black Diamond Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $16$15
Current: $4.18
Upside: +258.85%
ALX Oncology Holdings
Mar 7, 2025
Maintains: Hold
Price Target: $3$1.5
Current: $1.65
Upside: -9.09%
Cullinan Therapeutics
Feb 28, 2025
Maintains: Buy
Price Target: $23$19
Current: $8.74
Upside: +117.39%
Relay Therapeutics
Feb 27, 2025
Maintains: Buy
Price Target: $27$23
Current: $6.51
Upside: +253.30%
Arvinas
Feb 12, 2025
Maintains: Buy
Price Target: $63$51
Current: $9.68
Upside: +426.86%
Kura Oncology
Oct 14, 2024
Downgrades: Hold
Price Target: $26$19
Current: $10.13
Upside: +87.56%
Celcuity
Oct 7, 2024
Maintains: Buy
Price Target: $39$42
Current: $52.53
Upside: -20.05%
Summit Therapeutics
Sep 25, 2024
Maintains: Buy
Price Target: $25$40
Current: $21.97
Upside: +82.07%
Maintains: Buy
Price Target: $115$135
Current: $90.42
Upside: +49.30%
Initiates: Buy
Price Target: $20
Current: $13.30
Upside: +50.38%
Initiates: Buy
Price Target: $10
Current: $3.35
Upside: +198.51%
Maintains: Buy
Price Target: $32$10
Current: $1.56
Upside: +541.03%
Maintains: Buy
Price Target: $90$99
Current: $94.88
Upside: +4.34%
Maintains: Buy
Price Target: $13$14
Current: $2.48
Upside: +464.52%
Maintains: Buy
Price Target: $35$55
Current: $60.46
Upside: -9.03%